Panic Attack: Causes, Red Flags, Treatment & When to Seek Help

## Overview A **panic attack** is a sudden, intense surge of fear or discomfort that peaks within minutes and is accompanied by a constellation of physical and cognitive symptoms — racing heart, shortness of breath, chest tightness, dizziness, trembling, and an overwhelming sense of impending doom or loss of control. The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) requires at least four of thirteen characteristic symptoms for a formal panic attack designation. Panic attacks are remarkably common. Data from the National Comorbidity Survey Replication (NCS-R) indicate that approximately **22.7% of the U.S. adult population** will experience at least one isolated panic attack during their lifetime, while the 12-month prevalence of **panic disorder** (recurrent, unexpected panic attacks with persistent worry about future attacks) is roughly **2–3%** [1]. Women are affected approximately twice as often as men, and onset typically occurs in late adolescence or early adulthood. Panic attacks are one of the most frequently searched health symptoms online because their physical manifestations closely mimic life-threatening conditions such as myocardial infarction, pulmonary embolism, and anaphylaxis. Studies estimate that up to 25% of patients presenting to emergency departments with chest pain meet criteria for panic disorder [2]. Understanding when a panic attack is benign versus when it signals a medical emergency is therefore critically important. ICD-10 code: **F41.0** (Panic disorder [episodic paroxysmal anxiety]). --- ## Common Causes Panic attacks arise from a complex interplay of neurobiological, psychological, and environmental factors. Below are the most common causes and triggers, ranked approximately by frequency. ### 1. Panic Disorder (Most Common Recurrent Cause) Panic disorder involves recurrent, unexpected panic attacks without an identifiable external trigger. The underlying pathophysiology involves dysregulation of the **fear network** — particularly the amygdala, hippocampus, and prefrontal cortex — along with imbalances in serotonin, norepinephrine, and gamma-aminobutyric acid (GABA) neurotransmission [3]. The "suffocation false alarm" hypothesis suggests that individuals with panic disorder have a hypersensitive carbon dioxide (CO₂) detection system in the brainstem, triggering fight-or-flight responses inappropriately. ### 2. Generalized Anxiety Disorder and Other Anxiety Disorders Panic attacks frequently occur in the context of generalized anxiety disorder (GAD), social anxiety disorder, specific phobias, and post-traumatic stress disorder (PTSD). In these cases, panic attacks are typically **expected** — triggered by a known feared stimulus — rather than spontaneous. ### 3. Acute Psychosocial Stress Major life stressors (bereavement, job loss, relationship conflict, financial crisis) can precipitate panic attacks even in individuals without a pre-existing anxiety disorder. Chronic stress elevates baseline cortisol and catecholamine levels, lowering the threshold for sympathetic nervous system activation. ### 4. Substance Use and Withdrawal - **Caffeine** — a well-documented panicogenic agent, especially at doses above 400 mg/day - **Cannabis** — particularly high-THC strains can induce acute panic - **Stimulants** (cocaine, amphetamines) — direct sympathomimetic effects - **Alcohol withdrawal** — GABAergic rebound produces heightened excitability - **Benzodiazepine withdrawal** — similar mechanism - **Nicotine** — both acute use and withdrawal can trigger episodes ### 5. Medical Conditions That Mimic or Trigger Panic Attacks - **Hyperthyroidism** — excess thyroid hormones amplify adrenergic signaling - **Pheochromocytoma** — catecholamine-secreting tumor (rare but important) - **Cardiac arrhythmias** — supraventricular tachycardia in particular - **Mitral valve prolapse** — historically associated, though causality is debated - **Hypoglycemia** — counter-regulatory hormone release mimics panic - **Vestibular dysfunction** — dizziness triggers panic through interoceptive conditioning - **Respiratory conditions** (asthma, COPD) — dyspnea may trigger fear cascades ### 6. Medication Side Effects Several medications can provoke panic-like symptoms, including selective serotonin reuptake inhibitors (SSRIs) during the initial 1–2 weeks of treatment ("activation syndrome"), thyroid hormone replacement at supraphysiologic doses, corticosteroids, decongestants (pseudoephedrine), and certain asthma medications (e.g., albuterol). --- ## RED FLAGS Because panic attack symptoms overlap significantly with life-threatening conditions, the following **red flags** warrant **immediate emergency evaluation (call 911 or go to the nearest ER)**: - **Crushing or pressure-like chest pain** radiating to the left arm, jaw, neck, or back — may indicate myocardial infarction - **Sudden-onset severe headache** ("thunderclap headache") — may indicate subarachnoid hemorrhage - **Unilateral weakness, facial droop, or speech difficulty** — stroke symptoms - **Sustained heart rate >150 bpm** or irregular/erratic pulse — possible arrhythmia - **Severe shortness of breath with low oxygen saturation** (SpO₂ <94%) — possible pulmonary embolism, pneumothorax, or anaphylaxis - **Lip/tongue swelling, hives, or throat tightness** following allergen exposure — anaphylaxis - **Loss of consciousness or syncope** during or after the episode - **Active suicidal ideation** or self-harm urges during or after the panic attack - **First-ever episode in a person over age 50** with no prior anxiety history — higher likelihood of cardiac or metabolic etiology - **Symptoms that do not resolve within 20–30 minutes** or progressively worsen - **Recent major surgery, immobilization, or hormonal contraceptive use** combined with chest pain and dyspnea — risk factors for pulmonary embolism > **Important:** If you are unsure whether you are experiencing a panic attack or a cardiac event, always err on the side of seeking emergency care. It is far safer to be evaluated and reassured than to dismiss a potentially dangerous condition. --- ## Self-Care at Home The following evidence-based, non-pharmacological strategies may help manage acute panic attacks and reduce their frequency over time. ### During an Acute Attack 1. **Diaphragmatic (slow) breathing** — Breathe in slowly through the nose for 4 seconds, hold for 2 seconds, exhale through pursed lips for 6 seconds. This activates the parasympathetic nervous system and counteracts hyperventilation-induced respiratory alkalosis. A 2010 study demonstrated that respiratory retraining was a key mediator of treatment response in panic disorder [7]. 2. **Grounding techniques (5-4-3-2-1 method)** — Identify 5 things you can see, 4 you can touch, 3 you can hear, 2 you can smell, and 1 you can taste. This redirects attention from interoceptive threat cues to external sensory stimuli. 3. **Progressive muscle relaxation** — Systematically tense and release major muscle groups. This reduces the somatic component of panic. 4. **Self-reassurance and cognitive reappraisal** — Remind yourself: "This is a panic attack. It is temporary. It is not dangerous. It will pass." Cognitive reframing of catastrophic interpretations is a core component of CBT for panic [4]. ### For Long-Term Prevention 5. **Regular aerobic exercise** — A meta-analysis demonstrated that moderate-intensity exercise (e.g., 150 minutes/week of brisk walking or jogging) has a significant anxiolytic effect comparable to some pharmacotherapies [5]. Exercise reduces baseline sympathetic tone and increases endogenous endorphin and endocannabinoid levels. 6. **Sleep hygiene** — Sleep deprivation lowers the panic threshold. Aim for 7–9 hours per night with consistent sleep-wake times. 7. **Caffeine reduction** — Gradually reduce caffeine intake, as abrupt cessation can itself trigger anxiety. Target <200 mg/day or elimination if sensitive. 8. **Alcohol moderation or avoidance** — While alcohol may temporarily reduce anxiety, rebound effects and withdrawal-related sympathetic activation worsen panic in the medium term. 9. **Mindfulness meditation** — Regular mindfulness practice (e.g., 10–20 minutes daily) has been shown to reduce anxiety sensitivity, a key vulnerability factor for panic attacks [3]. 10. **Limiting reassurance-seeking and avoidance behaviors** — Paradoxically, excessive self-checking (e.g., repeated pulse-taking) and avoidance of feared situations reinforce the fear cycle. Gradual exposure, ideally guided by a therapist, is the gold standard. --- ## OTC Medications That May Help No OTC medication is specifically approved for treating panic attacks. However, certain supplements and over-the-counter agents have limited evidence suggesting anxiolytic properties. These should generally be considered **adjuncts** to, not replacements for, professional care. | Class | Example | Typical Adult Dose | Mechanism | Notes / Contraindications | |---|---|---|---|---| | Antihistamine (sedating) | Diphenhydramine (Benadryl) | 25–50 mg as needed (max 300 mg/day) | H1-receptor antagonism in the CNS produces mild sedation and anxiolysis | Not for long-term use; anticholinergic side effects (dry mouth, urinary retention, confusion in elderly); avoid with MAOIs; may cause paradoxical excitation | | Herbal – Valerian root | Valerian extract | 300–600 mg, 30–60 min before bedtime or stressful event | Modulates GABA-A receptors | Limited evidence for panic specifically; generally well tolerated; may potentiate other CNS depressants | | Herbal – Lavender oil | Silexan (Lavela WS 1265) | 80–160 mg/day (oral capsule) | Modulates voltage-dependent calcium channels; inhibits serotonin transporter | A 2014 randomized trial showed efficacy comparable to lorazepam 0.5 mg/day for generalized anxiety [6]; available OTC in some countries; GI upset possible | | Herbal – Passionflower | *Passiflora incarnata* extract | 200–400 mg/day (standardized extract) | GABAergic modulation | Small studies show anxiolytic effect; may cause drowsiness; limited safety data in pregnancy | | Magnesium | Magnesium glycinate or citrate | 200–400 mg/day | NMDA receptor modulation; HPA axis regulation | May help in individuals with low magnesium levels; diarrhea at high doses (especially citrate); reduce dose in renal impairment | | L-theanine | L-theanine (from green tea) | 200–400 mg/day | Increases alpha brain-wave activity; modulates glutamate and GABA | Generally well tolerated; limited large-scale evidence for panic; may lower blood pressure | > **Caution:** OTC antihistamines like diphenhydramine should not be used regularly for anxiety, as tolerance develops rapidly and anticholinergic burden carries risks, especially in older adults. Herbal supplements can interact with prescription medications — always inform your clinician of all supplements you take. --- ## Prescription Options Prescription treatment for panic disorder is generally indicated when panic attacks are recurrent, cause significant functional impairment, or do not respond to self-care and psychotherapy alone. Treatment is typically prescribed by a **primary care physician, psychiatrist, or psychiatric nurse practitioner**. ### First-Line: Psychotherapy **Cognitive Behavioral Therapy (CBT)** is the most robustly evidence-based treatment for panic disorder, with response rates of 70–90% in controlled trials [4]. CBT for panic typically includes psychoeducation, cognitive restructuring of catastrophic misinterpretations, interoceptive exposure, and in vivo exposure. A Cochrane review confirmed its superiority over other psychotherapies for panic disorder [8]. CBT is generally delivered over 12–16 weekly sessions. ### First-Line Pharmacotherapy | Class | Examples | Typical Adult Starting Dose | Target Dose | Notes | |---|---|---|---|---| | **SSRIs** | Sertraline (Zoloft), Paroxetine (Paxil), Fluoxetine (Prozac), Escitalopram (Lexapro) | Sertraline 25 mg/day; Paroxetine 10 mg/day; Escitalopram 5 mg/day | Sertraline 50–200 mg/day; Paroxetine 20–60 mg/day; Escitalopram 10–20 mg/day | First-line per NICE and APA guidelines [5][9]; onset 2–4 weeks; may transiently worsen anxiety in week 1–2; taper gradually to avoid discontinuation syndrome | | **SNRIs** | Venlafaxine XR (Effexor XR) | 37.5 mg/day | 75–225 mg/day | First-line alternative; monitor blood pressure at higher doses; discontinuation syndrome common | ### Second-Line / Adjunct Pharmacotherapy | Class | Examples | Typical Adult Dose | Notes | |---|---|---|---| | **Benzodiazepines** | Alprazolam (Xanax), Clonazepam (Klonopin), Lorazepam (Ativan) | Alprazolam 0.25–0.5 mg TID; Clonazepam 0.25–0.5 mg BID | Rapid onset (minutes); effective for acute relief; **significant risks**: dependence, tolerance, withdrawal seizures, cognitive impairment; DEA Schedule IV; generally reserved for short-term bridging while SSRIs take effect; avoid in patients with substance use history | | **Tricyclic antidepressants (TCAs)** | Imipramine, Clomipramine | Imipramine 25 mg/day titrated to 100–300 mg/day | Well-established efficacy but more side effects than SSRIs (anticholinergic, cardiac conduction changes, weight gain); overdose risk; ECG monitoring advisable | | **Buspirone** | Buspirone (BuSpar) | 5 mg TID, titrated to 15–60 mg/day | 5-HT1A partial agonist; less effective for acute panic than for GAD; no dependence risk; slow onset (2–4 weeks) | | **MAOIs** | Phenelzine (Nardil) | 15 mg TID, titrated up | Highly effective but rarely used due to dietary restrictions (tyramine) and drug interactions; typically reserved for treatment-resistant cases | | **Anticonvulsants** | Pregabalin, Gabapentin | Pregabalin 75 mg BID (off-label in U.S.) | Approved for GAD in Europe; some evidence for panic; dizziness, weight gain; potential for misuse | > **Key principle:** Current guidelines recommend **combined CBT plus SSRI/SNRI** for moderate-to-severe panic disorder, as combination treatment generally yields higher response and remission rates than either alone [5]. --- ## Lab Tests Typically Ordered When a patient presents with panic attacks — especially a first episode, atypical features, or treatment resistance — clinicians may order laboratory tests to rule out medical mimics. | Test | Rationale | Link | |---|---|---| | **Thyroid function tests (TSH, free T4)** | Hyperthyroidism causes tachycardia, tremor, anxiety, and heat intolerance that closely mimic panic | [Thyroid Panel](/tests/thyroid-panel) | | **Complete blood count (CBC)** | Anemia can cause palpitations, dyspnea, and dizziness | [CBC](/tests/complete-blood-count) | | **Basic metabolic panel (BMP)** | Electrolyte abnormalities (hypokalemia, hypocalcemia, hypomagnesemia) and hypoglycemia can trigger or mimic panic | [BMP](/tests/basic-metabolic-panel) | | **12-lead ECG** | Rules out arrhythmias (SVT, atrial fibrillation, Wolff-Parkinson-White syndrome), prolonged QT interval, and ischemic changes | [ECG](/tests/electrocardiogram) | | **Urine drug screen** | Identifies stimulant use (cocaine, amphetamines) or other substances contributing to symptoms | [Urine Drug Screen](/tests/urine-drug-screen) | | **24-hour urine catecholamines / plasma metanephrines** | Ordered when pheochromocytoma is suspected (episodic hypertension, headache, diaphoresis with panic) — rare but important | [Metanephrines](/tests/plasma-metanephrines) | | **Cortisol (morning serum or 24-hour urine)** | Cushing syndrome can present with anxiety, weight gain, and hypertension | [Cortisol](/tests/cortisol-test) | | **Echocardiogram** | May be ordered if a murmur is detected or mitral valve prolapse is suspected | [Echocardiogram](/tests/echocardiogram) | | **Pulmonary function tests** | If asthma or other respiratory conditions are suspected as contributing factors | [PFTs](/tests/pulmonary-function-tests) | In most cases, these tests return normal results, which itself can be therapeutically reassuring for the patient. However, a **normal workup does not mean the symptoms are "not real"** — panic attacks involve genuine physiological activation. --- ## Special Populations ### Children and Adolescents - Panic disorder is uncommon before puberty but increases significantly in adolescence (prevalence ~1–2% in teens) - Children may describe panic attacks differently — "tummy aches," "feeling weird," clinging behavior — and may not articulate cognitive symptoms like derealization - **CBT adapted for children (including parental involvement)** is first-line treatment per AACAP guidelines - **Pharmacotherapy:** SSRIs (fluoxetine, sertraline) are generally considered first-line when medication is needed. **Dosing must follow pediatric-specific references and be initiated and monitored by a specialist.** Benzodiazepines are generally avoided in pediatric populations due to disinhibition risk and limited safety data - Close monitoring for suicidality is essential per the FDA black-box warning on SSRIs in patients under 25 ### Pregnancy and Postpartum - Panic disorder may worsen, improve, or emerge de novo during pregnancy - **Non-pharmacological approaches (CBT, relaxation training)** are preferred as first-line - Among SSRIs, **sertraline** is generally considered the preferred option in pregnancy due to relatively more safety data and low transfer into breast milk (ACOG Committee Opinion) - **Paroxetine** carries an FDA Category D warning due to potential increased risk of cardiac malformations with first-trimester exposure — it should generally be avoided in pregnancy - **Benzodiazepines** in pregnancy are associated with potential risks including neonatal adaptation syndrome; use should be reserved for severe cases with specialist guidance - All treatment decisions should involve a **risk-benefit discussion between the patient and a perinatal psychiatrist or maternal-fetal medicine specialist** ### Elderly Adults (≥65 years) - Panic disorder prevalence decreases with age, but new-onset panic symptoms in older adults warrant thorough medical evaluation (cardiac disease, pulmonary disease, medication effects) - **Benzodiazepines are listed on the Beers Criteria** as potentially inappropriate for older adults due to increased risk of falls, fractures, cognitive impairment, and delirium - SSRIs should be started at **lower doses** (e.g., sertraline 12.5–25 mg/day) and titrated slowly — "start low and go slow" - **Diphenhydramine** and other anticholinergic OTC options are particularly risky in this population (confusion, urinary retention, falls) - CBT is effective and safe in older adults and should be strongly considered as first-line ### Athletes - Panic attacks can occur during or after intense exertion and may be difficult to distinguish from exercise-induced arrhythmias or exercise-induced asthma - Athletes should have a **cardiac evaluation** (ECG, possibly echocardiogram) before attributing exertional symptoms to panic - Beta-blockers, sometimes used off-label for performance anxiety, are **banned in certain sports** by the World Anti-Doping Agency (WADA) — athletes should consult sports medicine physicians - SSRIs are not on the WADA prohibited list and are generally safe for use in athletes - Benzodiazepines may impair coordination, reaction time, and performance - Exercise itself is therapeutic for panic disorder — there is no need to restrict training unless cardiac pathology is identified --- ## When to Escalate Use the following thresholds as a general guide. When in doubt, always seek care sooner. ### Same-Day GP / Primary Care Visit - First-ever panic attack (to establish diagnosis and rule out medical causes) - Recurrent panic attacks interfering with work, school, or relationships - Development of agoraphobia (avoiding places or situations due to fear of panic) - Desire to discuss medication options or therapy referral - Side effects from current anxiety medication ### Urgent Care (Same Day or Within 24 Hours) - Panic attacks occurring multiple times per day - Panic attack with prolonged symptoms (>30 minutes) that eventually resolve - Suspected medication reaction or supplement interaction causing panic-like symptoms - Moderate suicidal thoughts without active plan ### Emergency Room / Call 911 - **Any symptom pattern that could indicate a cardiac event** — chest pain with radiation, diaphoresis, nausea, jaw pain — especially in those with cardiovascular risk factors - **Active suicidal ideation with a plan or intent**, or self-harm during a panic episode — call 988 (Suicide & Crisis Lifeline) or 911 - Syncope (fainting) during a panic attack - Seizure-like activity - Severe allergic reaction symptoms (angioedema, stridor, hypotension) - Symptoms suggesting pulmonary embolism (sudden pleuritic chest pain, hemoptysis, tachycardia, recent immobilization or surgery) - Altered mental status or confusion that does not clear as the panic subsides > **Remember:** Panic disorder is highly treatable. With appropriate therapy, medication, or both, the majority of individuals experience significant improvement. Seeking help is a sign of strength, not weakness. --- ## References [1] Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE. The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. *Arch Gen Psychiatry*. 2006;63(4):415-424. PMID:16585471. [2] Fleet RP, Dupuis G, Marchand A, Burelle D, Arsenault A, Beitman BD. Panic disorder in emergency department chest pain patients: prevalence, comorbidity, suicidal ideation, and physician recognition. *Am J Med*. 1996;101(4):371-380. PMID:8873507. [3] Craske MG, Stein MB. Anxiety. *Lancet*. 2016;388(10063):3048-3059. PMID:27349358. [4] Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. *J Clin Psychiatry*. 2008;69(4):621-632. PMID:18363421. [5] National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. Published January 2011, last updated June 2020. Available at: https://www.nice.org.uk/guidance/cg113. [6] Woelk H, Schläfke S. A multi-center, double-blind, randomised study of the lavender oil preparation Silexan in comparison to lorazepam for generalized anxiety disorder. *Phytomedicine*. 2010;17(2):94-99. PMID:19962288. [7] Meuret AE, Rosenfield D, Seidel A, Bhaskara L, Hofmann SG. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity. *J Consult Clin Psychol*. 2010;78(5):691-704. PMID:20873904. [8] Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O, Salanti G. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. *Cochrane Database Syst Rev*. 2016;4:CD011004. PMID:27071857. [9] American Psychiatric Association. Practice guideline for the treatment of patients with panic disorder. 2nd ed. *Am J Psychiatry*. 2009;166(Suppl):1-68. Available at: https://psychiatryonline.org/guidelines.